跳至主要内容
临床试验/ACTRN12624000707561
ACTRN12624000707561进行中(未招募)Unknown

Protocol for a Randomised Controlled Trial to evaluate psychosocial and behaviour impact of providing personalised risk scores for melanoma in a high-risk, adult cohort.

The University of Queensland0 个研究点目标入组 145 人开始时间: 2024年6月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • This is a sub-study from a larger trial (ACTRN12619001706167). This study will recruit 360 individuals in a longitudinal two-arm randomised controlled, single-blind trial. Individuals are recruited from a cohort of previous and existing study participants within the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) Study (ethical approval reference: HREC/2019/QMS/57206). The setting is at the Princess Alexandra Hospital located in Brisbane, Queensland, Australia. Participants in this study represented various risk levels (low, moderate, and high risk) and range from 18 years old and up. Any participant who has previously provided a saliva sample for genetic analysis, and consented to be contacted for future research are eligible to be recruited to the present study.

排除标准

  • If not already enrolled in parent (ACEMID) trial, individuals are not eligible to participate.

研究者

相似试验

Protocol for a Randomised Controlled Trial to... | 临床试验